COVID-19 vaccine update: DGCI panel gives nod to phase 3 trials of Bharat Biotech's Covaxin
The recommendation was given by the panel after assessing the data of phase 1 and 2 clinical trials as well as animal challenge study.
Full Article
COVID-19 vaccine update: DGCI panel gives nod to phase 3 trials of Bharat Biotech's Covaxin
DNA
0 shares
1 views
You might like
Related news coverage
DCGI's expert panel recommends Phase 3 clinical trial nod for Bharat Biotech's Covid-19 vaccine
The expert panel at Central Drugs Standard Control Organisation (CDSCO) has recommended the top drugs regulator to grant permission..
Mid-Day
Covaxin: Bharat Biotech gets DCGI nod for Phase 3 trial of its coronavirus vaccine
The coronavirus vaccine being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR)..
Zee News